A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.
AMA J Ethics. 2021;23(9):E712-720. doi:
10.1001/amajethics.2021.712.
Iris G. Insogna, MD, MBE and Elizabeth S. Ginsburg, MD
Although the World Health Organization defines infertility as a disease, insurance coverage gaps generate disparities in access to care and treatment, especially for tubal factor infertility and oncofertility.
AMA J Ethics. 2018;20(12):E1152-1159. doi:
10.1001/amajethics.2018.1152.
Victoire Fokom Defo, MD and Joël Fokom Domgue, MD, MPH
HPV tests are alternatives to Pap smear screening that enable women to self-collect specimens and might be the best cervical cancer prevention strategy for many.
AMA J Ethics. 2020;22(2):E116-125. doi:
10.1001/amajethics.2020.116.
Madeleine (Maddy) Kane, Rachel Bervell, MD, MS, Angela Y. Zhang, MD, and Jennifer Tsai, MD, MEd
Algorithms use race as an epidemiological shorthand, but clinically influential historical, social, and cultural determinants of health are still sources of variability.
AMA J Ethics. 2022;24(8):E720-728. doi:
10.1001/amajethics.2022.720.
Professor Katie Watson joins Ethics Talk to consider key questions about clinical and legal risk management for clinicians trying keep patients safe and for patients with complex pregnancies trying to stay alive.
Dr Liam G. McCoy joins Ethics Talk to discuss his article, coauthored with Drs Zainab Doleeb, Jazleen Dada, and Catherine Allaire: “Underrecognition of Dysmenorrhea Is an Iatrogenic Harm.”
Andrew M. Courtwright, MA and Mia Wechsler Doron, MTS, MD
A positive right to parenthood obligates others to support a person’s attempt to become a parent. Do physicians have a duty to assist their patients’ procreative efforts, and, if so, in what ways?